Table 1.
Parameter | Point Estimate | Min | Max | Sources |
---|---|---|---|---|
Epidemiological model | ||||
The proportion of the at-risk population infected | 10% | 5% | 15% | [10, 13, 15] |
The proportion of those infected with chronic disease | 33.3% | ... | ... | [10–12] |
The proportion of those with chronic disease with hydrocele | 62.5% | ... | ... | [10–12] |
The proportion of those with chronic disease with lymphedema | 37.5% | ... | ... | [10–12] |
Annual incidence of ADL episodes, per 1000 infected individuals | 780 | ... | ... | [16–19] |
Average duration of an ADL episode, days | 4.7 | 1 | 11 | [16–19] |
Reductions in productivity | ||||
During an ADL episode | 77.5% | 72.5% | 84.5% | [20] |
With hydrocoele | 17.7% | 13.8% | 20.4% | [20] |
With lymphoedema | 16.0% | 10.0% | 21.3% | [20] |
Economic value of a lost productive day | ||||
GDP per capita of the lowest income quintile | Average: US $2.20a | ... | ... | [21] |
Daily minimum wage (based on USDoS) | Average: US $2.78a | ... | ... | [22] |
Daily minimum wage (based on ILOSTAT) | Average: US$ 2.44a | ... | ... | [23] |
DALY disability weights | ||||
ADL disability weight | 0.051 | 0.032 | 0.074 | [14] |
Hydrocoele disability weight | 0.128 | 0.086 | 0.180 | [14] |
Lymphoedema disability weight | 0.109 | 0.073 | 0.154 | [14] |
Parameters relating to treatment seeking are shown in Supplementary Table S3 and Supplementary Figure 1. Costs are in 2016 US$.Abbreviations: ADL, adenolymphangitis; DALY, disability-adjusted life years; GDP, gross domestic product; ILOSTAT, International Labor Organization Statistics; USDoS, United States Department of State.
aThe economic value of a lost productive day was estimated for each endemic country. The values shown are the global averages (weighted by the countries’ at-risk populations).